Artivion Inc.
Price
Key statistics
- Forward rate
- $0.12
- Yield
- 0.58%
- Payout ratio
- 0.00%
- Frequency
- Quarterly
- 2015-12-09$0.03
Artivion Inc. is a medical device company focused on cardiac and vascular surgery, with a particular emphasis on the treatment of aortic disease. Artivion develops, manufactures, processes, and distributes a broad portfolio of products used in complex surgical procedures, including aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable human tissues for cardiac and vascular applications. Its offerings support surgeons in open, hybrid, and minimally invasive procedures, making the company a specialized supplier in advanced cardiovascular care. Artivion also provides tissue preservation services, extending its role beyond devices into biologic solutions used in transplant and reconstructive settings. With products sold across global markets, Artivion occupies an important niche in the medical technology sector centered on aortic repair and cardiovascular surgery.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. James Patrick Mackin
- Employees
- 1,800
- Headquarters
- Kennesaw, GA, United States
- Website
- artivion.com